Quest Diagnostics, Inc.
DGX
Market Cap$20.31B
Close$
Earnings Call Q2 2025
July 22, 2025 - AI Summary
Strong Revenue Growth: Quest Diagnostics reported consolidated revenues of $2.76 billion for Q2 2025, reflecting a 15.2% increase year-over-year. This growth was driven by both acquisitions and a 5.2% organic revenue growth, indicating strong demand for innovative clinical solutions, alongside the expansion of enterprise accounts.
Updated Financial Guidance: The company raised its full-year revenue guidance to a range of $10.8 billion to $10.92 billion, with reported EPS projected between $8.60 to $8.80 and adjusted EPS between $9.63 to $9.83. This adjustment reflects a continuation of solid performance and utilization trends.
Challenges from Uninsured Rates and Regulations: The potential increase in uninsured rates due to legislative changes (referred to as the "One Big Beautiful Bill") could lead to a 30-40 basis point impact on volumes in 2026. However, the company expects this to be manageable, estimating the impact from Medicaid falls to be minimal.
Exclusive for Stockcircle Pro members
Sign up
$318.88
77% upside
Current Fair Value
77% upsideUndervalued by 77% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $20.31 Billion |
|---|---|
| Enterprise Value | $26.38 Billion |
| Dividend Yield | $3.10 (1.71%) |
| Earnings per Share | $7.8 |
| Beta | 0.46 |
| Outstanding Shares | 112,000,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 21.44 |
|---|---|
| PEG | 92.22 |
| Price to Sales | 1.94 |
| Price to Book Ratio | 2.77 |
| Enterprise Value to Revenue | 2.51 |
| Enterprise Value to EBIT | 24.31 |
| Enterprise Value to Net Income | 19 |
| Total Debt to Enterprise | 0.24 |
| Debt to Equity | 0.88 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Quest Diagnostics, Inc.
47,000 employees
CEO: Stephen Rusckowski Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy beh...